Shares of Jazz Pharmaceuticals PLC rose today after an industry website said it would likely be the most viable deal target for Irvine-based Allergan Inc.
Dublin-based Jazz’s shares closed up 7% to a market value of $10.1 billion.
Allergan is fighting a hostile takeover bid from Canada’s Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman’s Pershing Square Capital Management LP.
Help employers find you! Check out all the jobs and post your resume.
